Form D · Other Health Care
Empire Genomics, LLC
Buffalo, NY · CIK 0001608855
Offering snapshot reported Mar 17, 2016 · SEC filing
- Reported sold
- $300K Offering amount: $750K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 1, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 17, 2016 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Nov 19, 2014 | Amendment | $1,250,000 | $250,000vs Jul 9, 2014 | 4 | SEC filing |
| Jul 9, 2014 | Initial | $1,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-259481
Source: Form D, filed Mar 17, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Edward Chait | Director |
| Anthony Johnson | Director, Executive, Promoter |
| Norma Nowak | Director |
| Daniel Penberthy | Director |
| Michael B. Sexton | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
700 Michigan St., Suite 200
Buffalo, NY, 14203
Buffalo, NY, 14203